• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzenesulfonamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides Aminobenzenesulfonamides

Introduction to 4-Amino-N-(3-fluorophenyl)benzenesulfonamide (CAS No. 1494-84-4)

4-Amino-N-(3-fluorophenyl)benzenesulfonamide, identified by the Chemical Abstracts Service Number (CAS No.) 1494-84-4, is a sulfonamide derivative that has garnered significant attention in the field of medicinal chemistry and pharmaceutical research. This compound belongs to a class of molecules known for their diverse biological activities, making it a subject of extensive study in drug discovery and development.

The molecular structure of 4-amino-N-(3-fluorophenyl)benzenesulfonamide consists of a benzenesulfonamide core substituted with an amino group at the 4-position and a 3-fluorophenyl group at the nitrogen atom. The presence of the fluorine atom introduces unique electronic and steric properties, which can influence the compound's interactions with biological targets. This structural feature has been exploited in the design of molecules with enhanced binding affinity and selectivity, crucial factors in developing effective therapeutic agents.

In recent years, sulfonamide derivatives have been extensively explored for their potential in treating various diseases, including infectious diseases, cancer, and inflammatory conditions. The fluorine substitution in 4-amino-N-(3-fluorophenyl)benzenesulfonamide is particularly noteworthy, as fluorinated aromatic compounds often exhibit improved metabolic stability and bioavailability. These attributes make them attractive candidates for further development into novel drugs.

One of the most compelling aspects of 4-amino-N-(3-fluorophenyl)benzenesulfonamide is its reported activity as an inhibitor of certain enzymes and receptors involved in disease pathways. For instance, studies have suggested that this compound may interact with targets such as dihydrofolate reductase (DHFR) and tyrosine kinases, which are implicated in cancer cell proliferation. The fluorine atom's ability to enhance binding interactions has been demonstrated to improve the efficacy of such inhibitors.

Moreover, the sulfonamide moiety is known for its ability to form hydrogen bonds with biological targets, a property that enhances the compound's binding affinity. The amino group at the 4-position of the benzene ring further contributes to its interactions with biological molecules by participating in hydrogen bonding or salt formation. These structural features make 4-amino-N-(3-fluorophenyl)benzenesulfonamide a versatile scaffold for drug design.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to predict the binding modes of 4-amino-N-(3-fluorophenyl)benzenesulfonamide with high precision. These studies have provided valuable insights into how the compound interacts with its biological targets at the atomic level. Such detailed understanding is crucial for optimizing its pharmacological properties and developing derivatives with improved therapeutic profiles.

The synthesis of 4-amino-N-(3-fluorophenyl)benzenesulfonamide has also been refined over time, leading to more efficient and scalable methods. Modern synthetic approaches often involve multi-step reactions that incorporate fluorinated aromatic rings in a controlled manner. These methods ensure high yields and purity, which are essential for subsequent biological evaluation.

In clinical settings, compounds like 4-amino-N-(3-fluorophenyl)benzenesulfonamide are being evaluated for their potential therapeutic applications. Preclinical studies have shown promising results in models of cancer and inflammation, highlighting its potential as a lead compound for drug development. The ability to modulate disease pathways through precise molecular interactions makes this compound an attractive candidate for further investigation.

The role of fluorine in medicinal chemistry cannot be overstated, as it significantly impacts the pharmacokinetic properties of drugs. The introduction of fluorine into aromatic rings can alter lipophilicity, metabolic stability, and binding affinity. In the case of 4-amino-N-(3-fluorophenyl)benzenesulfonamide, these effects contribute to its potential as a therapeutic agent by enhancing its interaction with biological targets while minimizing off-target effects.

Future research on 4-amino-N-(3-fluorophenyl)benzenesulfonamide may focus on developing analogs with improved pharmacological properties. By modifying various structural features, such as substituents on the benzene ring or additional functional groups, researchers can fine-tune its activity against specific targets. Such modifications could lead to novel drugs with enhanced efficacy and reduced side effects.

The integration of machine learning and artificial intelligence into drug discovery has also opened new avenues for exploring the potential of compounds like 4-amino-N-(3-fluorophenyl)benzenesulfonamide. These technologies enable rapid screening of large chemical libraries and prediction of biological activity, accelerating the process of identifying promising drug candidates.

In conclusion, 4-amino-N-(3-fluorophenyl)benzenesulfonamide (CAS No. 1494-84-4) represents a significant advancement in medicinal chemistry due to its unique structural features and reported biological activities. Its potential as a therapeutic agent continues to be explored through both experimental and computational approaches. As research progresses, this compound may contribute to the development of novel treatments for various diseases.

• 312-52-7(4-Fluoro-N-phenylbenzenesulfonamide)
• 312-63-0(ELN484228)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)